Benjamin Cravatt III
Benjamin Franklin Cravatt III is a professor in the Department of Chemistry at The Scripps Research Institute in La Jolla, California. Considered a co-inventor of activity-based proteomics and a substantial contributor to research on the endocannabinoid system, he is a prominent figure in the nascent field of chemical biology. Cravatt was elected to the National Academy of Sciences in 2014, and the American Academy of Arts and Sciences in 2016. He is Gilula Chair of Chemical Biology, a Cope Scholar, and a Searle Scholar.
Benjamin F. Cravatt III | |
|---|---|
| Born | April 13, 1970 Houston, Texas, USA |
| Education | Stanford University B.S. and B.A. (1992) The Scripps Research Institute Ph.D. (1996) |
| Known for | Proteomics |
| Scientific career | |
| Fields | Chemical Biology |
| Institutions | The Scripps Research Institute Vividion Therapeutics ActivX Biosciences Abide Therapeutics |
| Doctoral advisors |
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.